Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,770Revenue (TTM) $M10,627Net Margin (%)-7.1Altman Z-Score0.4
Enterprise Value $M39,413EPS (TTM) $-2.2Operating Margin %9.8Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-6.5Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %19.7Quick Ratio1.1Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %87.2Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow3.9y-y EBITDA Growth Rate %12.7ROA % (ttm)-1.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-12.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M343ROIC % (ttm)-10.0Gross Margin Increase y-yY

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXGlenn Greenberg 2016-03-31 Reduce-17.01%$26.3 - $102.4
($74.84)
$ 23.13-69%Reduce -67.46%2,034,281
VRXRuane Cunniff 2016-03-31 Reduce-2.93%$26.3 - $102.4
($74.84)
$ 23.13-69%Reduce -14.32%30,308,449
VRXSteve Mandel 2016-03-31 Sold Out -2.53%$26.3 - $102.4
($74.84)
$ 23.13-69%Sold Out0
VRXBill Ackman 2016-03-31 Add1.48%$26.3 - $102.4
($74.84)
$ 23.13-69%Add 30.14%21,591,122
VRXDavid Tepper 2016-03-31 Buy 0.44%$26.3 - $102.4
($74.84)
$ 23.13-69%New holding945,000
VRXChris Davis 2016-03-31 Add0.4%$26.3 - $102.4
($74.84)
$ 23.13-69%Add 91.34%7,240,337
VRXLou Simpson 2016-03-31 Reduce-0.36%$26.3 - $102.4
($74.84)
$ 23.13-69%Reduce -3.97%2,591,399
VRXArnold Schneider 2016-03-31 Buy 0.34%$26.3 - $102.4
($74.84)
$ 23.13-69%New holding66,000
VRXFirst Eagle Investment 2016-03-31 Reduce-0.04%$26.3 - $102.4
($74.84)
$ 23.13-69%Reduce -8.83%1,495,332
VRXPrivate Capital 2016-03-31 Add0.02%$26.3 - $102.4
($74.84)
$ 23.13-69%Add 1.97%342,916
VRXJoel Greenblatt 2016-03-31 Buy $26.3 - $102.4
($74.84)
$ 23.13-69%New holding15,088
VRXJohn Paulson 2016-03-31 Add$26.3 - $102.4
($74.84)
$ 23.13-69%Add 0.14%13,284,800
VRXBill Ackman 2015-12-31 Reduce-3.69%$70.32 - $182.32
($111.15)
$ 23.13-79%Reduce -14.80%16,591,122
VRXWallace Weitz 2015-12-31 Sold Out -3.52%$70.32 - $182.32
($111.15)
$ 23.13-79%Sold Out0
VRXJohn Paulson 2015-12-31 Add2.74%$70.32 - $182.32
($111.15)
$ 23.13-79%Add 49.22%13,265,900
VRXGlenn Greenberg 2015-12-31 Add2.72%$70.32 - $182.32
($111.15)
$ 23.13-79%Add 12.09%6,252,331
VRXLou Simpson 2015-12-31 Add2.51%$70.32 - $182.32
($111.15)
$ 23.13-79%Add 38.18%2,698,614
VRXLeon Cooperman 2015-12-31 Sold Out -1.75%$70.32 - $182.32
($111.15)
$ 23.13-79%Sold Out0
VRXSteve Mandel 2015-12-31 Reduce-1.23%$70.32 - $182.32
($111.15)
$ 23.13-79%Reduce -21.88%5,829,079
VRXChris Davis 2015-12-31 Add0.97%$70.32 - $182.32
($111.15)
$ 23.13-79%Add 150.74%3,784,012
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ross Thomas W. Sr.Director 2016-06-13Buy4,000$24.4-5.2view
PAPA JOSEPH CCHAIRMAN & CEO 2016-06-10Buy202,000$24.48-5.51view
Pearson J. MichaelCEO 2015-11-05Sell1,297,399$78.48-70.53view
Farmer Ronald HaroldDirector 2015-10-21Buy1,500$181.6-87.26view
Farmer Ronald HaroldDirector 2015-08-26Buy500$220-89.49view
Farmer Ronald HaroldDirector 2015-08-21Buy1,000$224.97-89.72view
Rosiello Robert L.EVP, CFO 2015-07-31Buy7,875$254.28-90.9view
Rosiello Robert L.Executive Vice President 2015-06-12Buy12,900$232.51-90.05view
UBBEN JEFFREY W 2015-06-10Sell4,200,000$220.24-89.5view
Farmer Ronald HaroldDirector 2015-06-09Buy1,000$260.63-91.13view

Press Releases about VRX :

Quarterly/Annual Reports about VRX:

News about VRX:

Articles On GuruFocus.com
Learn from Bill Ackman’s Mistakes Jul 18 2016 
Bill Ackman's Herbalife Settles with FTC, Stock Is Undervalued Jul 15 2016 
Bill Ackman's Herbalife Settles with FTC, Stock Is Undervalued Jul 15 2016 
Bill Ackman: Herbalife Bilking People, NBC Helping Valeant Short-Seller Make Money Jul 14 2016 
Sequoia Fund Addresses Valeant, New Buys, Board Changes in 2nd Quarter Letter Jul 13 2016 
Bernard Horn's Polaris Global Value Fund 2nd Quarter Letter Jul 12 2016 
Andreas Halvorsen Doubles Stake in Natural Gas Power Plant Company Jul 07 2016 
Steve Mandel Exits Position in Williams Companies in 1st Quarter Jun 24 2016 
Valeant CEO Joseph Papa Buys $5 Million of Company's Shares Jun 15 2016 
Ackman Cuts Stake in Air Products by Nearly 13 Million Shares Jun 13 2016 

More From Other Websites
Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors Jul 28 2016
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal... Jul 28 2016
5:04 pm Valeant Pharma appoints Sarah B. Kavanagh to serve as a director of the Board, effective... Jul 28 2016
Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors Jul 28 2016
Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors Jul 28 2016
Valeant Pharmaceuticals: Looking for Signs of Life Jul 28 2016
Pharming Reports on Financial Results for the First Six Months of 2016 Jul 28 2016
Factors That Could Lead to More Growth for Acthar Jul 27 2016
How Analysts Rate Mallinckrodt Compared to Its Peers Jul 26 2016
Progenics Receives $50 Million Milestone Payment Following FDA Approval of RELISTOR® Tablets for... Jul 26 2016
Progenics Receives $50 Million Milestone Payment Following FDA Approval of RELISTOR® Tablets for... Jul 26 2016
Specialty Pharma: Earnings Better Be Good…or Else Jul 25 2016
Most Popular Canadian Stocks Among Hedge Funds Jul 25 2016
Ackman's Bad Bets Costs $600 Million in Redemptions Jul 24 2016
[$$] Valeant: Not All Delays Are Created Equal Jul 22 2016
[$$] Overheard Jul 22 2016
CANADA STOCKS-TSX at highest close in year, 4th weekly gain; telecoms shine Jul 22 2016
‘Deficiencies’ at Bausch + Lomb manufacturing plant in Tampa put glaucoma drug on hold Jul 22 2016
Valeant Hits Another Bump Jul 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)